Skip to main content

African Medicinal Mushrooms: Source of Biopharmaceuticals for the Treatment of Noncommunicable Diseases – A Review

  • Chapter
  • First Online:
Medicinal Mushrooms

Abstract

African mushrooms remain underexploited for biopharmaceuticals for application in modern medicine. Yet, amidst the rich use of mushrooms in African folk medicine and the high rates of endemic diseases plaguing the continent, the need for a critical exposé of African mushrooms as biopharmaceuticals and phytoceuticals is imperative and hereby presented. Generally, mushrooms are rich sources of many bioactive compounds that are important to our health servicing. They are a good source of proteins that are important to all body functions. Mushroom proteins are of very high quality and are rich in the most important essential amino acids. They are an excellent source of most B vitamins, and the primary natural source of ergosterol or provitamin D, and also essential minerals such as zinc and selenium. Malnutrition and stunting are largely a health problem in rural Africa. Mushrooms are abundant in nutrients that can potentially stamp out nutritional deficiencies in African children. While many people who eat balanced diets receive all the needed minerals, some get more sodium than they need. Mushrooms have the benefits of low sodium, low cholesterol, and higher potassium and iron than most foods. Chitin which is present in many African mushrooms such as Pleurotus tuber-regium, Termitomyces spp., Pleurotus spp., and Agaricus spp. is the primary structural material in mushrooms and has been shown to be of immense value as dietary fiber. It can also be hydrolyzed to glucosamine, which is widely accepted by physicians for treatment of chronic diseases of aging people such as autoimmune disorders and arthritis. Also it is used as a valuable food supplement for the prevention and alleviation of osteoarthritis. β-Glucans widely identified in a number of African mushrooms such as Ganoderma spp., African truffles, and Agaricus spp. are valuable immune regulatory substances that can treat and manage different cancers, diabetes, and other cardiovascular disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

DNA:

Deoxyribonucleic acid

FDA:

Food and Drug Administration

HDL:

High-density lipoprotein

LDL:

Low-density lipoprotein

NCDs:

Noncommunicable Diseases

References

  • Albershiem P (1976) The primary cell wall. In: Bonner J, Varner JE (eds) Plant biochemistry, 3rd edn. Academic, New York, pp 226–274

    Google Scholar 

  • Aoyagi Y, Kasuga A, Sasaki H, Matuzawa M, Tsutagawa Y, Kawai H (1993) Chemical composition of shitake mushroom cultivated on logs and sawdust substrate beds and their relations to composition of the substrate. Nippon Shokuhin Kogyo Gakkaishi 40:771–775

    Article  CAS  Google Scholar 

  • Austin PR, Brine CJ, Castle JE, Zikakis JP (1981) Chitin: new facets of research. Science 212:749–753

    Article  CAS  Google Scholar 

  • Bano Z, Bhagya S, Srinivasan KS (1981) Essential amino acid composition and proximate analysis of the mushroom Pleurotus eous and P. florida. Mushroom Newslett Trop 1(3):6–10

    Google Scholar 

  • Braham R, Dawson B, Goodman C (2003) The effect of glucosamine supplementation on people experiencing regular knee pain. Br J Sports Med 37:45–49

    Article  CAS  Google Scholar 

  • Brzezinski R, LeHoux JG, Kelly A (2004) Clinical studies on the innocuousness of chitosan and its short-chain derivative generated by enzymatic hydrolysis. Asia Pacific J Clin Nutr 13:S96

    Google Scholar 

  • Chang ST (1972) The Chinese mushroom. The Chinese University of Hong Kong, Hong Kong, p 113

    Google Scholar 

  • Chang ST (1993) Mushroom biology: the impact on mushroom production and mushroom products. In: Chang et al (eds) Mushroom biology and mushroom products. The Chinese University Press, Hong Kong, pp 3–20

    Google Scholar 

  • Chang ST (1999) Global impact of edible and medicinal mushrooms on human welfare in the 21st Century: non-green revolution. Int J Med Mushrooms 1:1–7. https://doi.org/10.1615/IntJMedMushrooms.v1.i1.10

    Article  Google Scholar 

  • Cheung PC (1998) Plasma and hepatic cholesterol levels and fecal neutral sterol excretion are altered in hamsters fed straw mushroom diets. J Nutr 128:1512–1516

    Article  CAS  Google Scholar 

  • Chioza A, Ohga S (2014) Cultivated mushrooms in Malawi: a look at the present situation. Adv Microbiol 4(1):6–1174

    Article  Google Scholar 

  • Cho YW, Cho YN, Chung SH, Yoo G, Ko SW (1999) Water-soluble chitin as a wound healing accelerator. Biomaterials 20:2139–2145

    Article  CAS  Google Scholar 

  • FDA (1996) http://www.fda.gov/cder/guidance/cholesty.pdf

  • FDA (1998) http://www.fda.gov/cder/foi/label/1998/209261bl.pdf

  • FDA (2000) http://www.fda.gov/cder/foi/label/2000/211761bl.pdf

  • Fenton JI, Chlebek-Brown KA, Peters TL, Carson JP, Orth MW (2000) Glucosamine HCL reduces equine articular cartilage degradation in explant culture. Osteoarthritis Cartilage 8:258–265

    Article  CAS  Google Scholar 

  • Foster AB, Webber JM (1960) Chitin. Adv Carbohydrate Chem 15:371–393

    CAS  Google Scholar 

  • Furda I (1983) Aminopolysaccharides-their potential as dietary fiber. In: Furda I (ed) Unconventional sources of dietary fibers. American Chemical Society, Washington, DC, pp 105–122

    Chapter  Google Scholar 

  • Gallaher DD, Gallaher CM, Mahrt GJ, Carr TP, Hollingshead CH, Heslink R Jr, Wise J (2002) A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans. J Am College Nutr 21:428–433

    Article  CAS  Google Scholar 

  • Gordon DT, Williford CB (1983) Chitin and chitosan: influence on absorption in rats. In: Furda I (ed) Unconventional sources of dietary fibers. American Chemical Society, Washingon, DC, pp 155–184

    Chapter  Google Scholar 

  • Katz DL (2001) A scientific review of the health benefit of oats. The Quaker Oats Company. http://www.quakeroatmeal.com/healthpros/IHP/HealthBenefitsofOats.pdf

  • Kogure T (1975) On the specificity of mushroom Pleurotus ostreatus and Pleurotus spodoleucus extracts. Vox Sanguinis 29:221–227

    Article  CAS  Google Scholar 

  • Kurtzman RH Jr (1975) Mushrooms as a source of food proteins. In: Friedman M (ed) Protein nutritional quality of foods and feeds, part 2. Marcel Dekker, New York, pp 305–318

    Google Scholar 

  • Kurtzman RH Jr (1991) Dolomite upsets the carbon dioxide balance. Mushroom Sci 13:747–751

    Google Scholar 

  • Kurtzman RH Jr (1993) Analysis, digestibility and the nutritional value of mushrooms. In: Chang et al (eds) Mushroom biology and mushroom products. Chinese University Press, Shatin

    Google Scholar 

  • Kurtzman RH Jr (1997) Nutrition from mushrooms, understanding and reconciling available data. Mycoscience 40:247–253

    Article  Google Scholar 

  • Mattila P, Lampi AM, Ronkainen R, Toivo J, Piironen V (2002) Sterols and vitamin D2 contents in some wild and cultivated mushrooms. Food Chem 76:293–298. https://doi.org/10.1016/S0308-8146(01)00275-8

    Article  CAS  Google Scholar 

  • McCarty MF (1998) Enhanced synovial production of hyaluronic acid may explain rapid clinical responses to high-dose glucosamine in osteoarthritis. Med Hypotheses 50(6):507–510

    Article  CAS  Google Scholar 

  • Mello DM, Brian MS, Nielson D et al (2004) Comparison of inhibitory effects of glucosamine and mannosamine on bovine articular cartilage degradation in vitro. Am J Vet Res 65:1440–1445. https://doi.org/10.2460/ajvr.2004.65.1440

    Article  CAS  PubMed  Google Scholar 

  • Mpeketula PMG (2008) Indigenous mushroom species cultivation, processing and utilization for food security and conservation. National Research Council of Malawi, Conference Proceedings, Malawi, pp 95–105

    Google Scholar 

  • Noller CR (1951) Chemistry of organic compounds. WB Saunders, Philadelphia, p 885

    Google Scholar 

  • Okhuoya JA, Akpaja EO, Osemwegie OO, Oghenekaro AO, Ihayaere CA (2010) Nigerian mushrooms: underutilized non-wood forest resources. Environ Manag 14(1):43–54

    Google Scholar 

  • Ormrod DJ, Holmes CC, Miller TE (1998) Dietary chitosan inhibits hypercholesterolemia and atherogenesis in apolipoprotein E-deficient mouse model of atherosclerosis. Atherosclerosis 138(2):329–334

    Article  CAS  Google Scholar 

  • Orth MW, Peters TL, Hawkins JN (2002) Inhibition of articular cartilage degradation by glucosamine-HCL and chondroitin sulfate. Equine Vet J Suppl 34:224–229

    Article  Google Scholar 

  • Ortiz R, Sanchez R, Piez A, Montaio LF, Zenteno E (1992) Induction of intestinal malabsorption syndrome in rats fed with Agaricus bisporus mushroom lectin. J Agric Food Chem 40:1375–1378

    Article  CAS  Google Scholar 

  • Outila T, Mattila PH, Piironen VI, Lamberg-Allardt CJ (1999) Bioavailability of vitamin D from wild edible mushrooms (Cantharellus tubaeformis) as measured with a human bioassay. Am J Clin Nutr 69:95–98

    Article  CAS  Google Scholar 

  • Presant P, Kornfeld S (1972) Characterization of the cell surface receprot for the Agaricus bisporus Hemagglutinin. J Biol Chem 247(21):6937–6945

    CAS  PubMed  Google Scholar 

  • Razdan A, Pettersson R (1994) Effect of chitin and chitosan on nutrient digestibility and plasma lipid concentrations in broiler chickens. Br J Nutr 72:277–288

    Article  CAS  Google Scholar 

  • Robson G (1999) Hyphal cell biology. In: Oliver RP, Schweizer M (eds) Molecular fungal biology. Cambridge University Press, Cambridge, pp p164–p184

    Chapter  Google Scholar 

  • Sanchez JE, Huerta G, Montiel E (eds) (2002) Mushroom biology and mushroom products, Proceedings of the 1V international conference. University of Morelos, Cuernavaca, Mexico, p 468

    Google Scholar 

  • Su CH, Lin BW, Yu SY, Liu SW (2004) Use of Ganoderma tsugae for the treatment of human chronic skin ulcers. Mushroom Sci 16:659–662

    Google Scholar 

  • Wakita S (1976) Thiamine-destruction by mushrooms. Sci Rep Yokohama Natl Univ Sect 2 23:39–70

    Google Scholar 

  • Windholtz M (1983) The Merck Index, 10th ed. Merck & Co., Rahway, pp 1463–1481

    Google Scholar 

  • Wittliff JL, Airth RL (1970) Thiaminase I. (Thiamine: base 2-methyl-4aminopyrimidine-5-methenyl transferase, EC 2.5.1.2). Methods Enzymol 18(A):234–238. https://doi.org/10.1016/0076-6879(71)18310-3

    Article  Google Scholar 

  • Yongabi KA (2007) Ethnomycology of grassland fields and tropical rainforest of Cameroon. Poster presentation at the ‘First World Conference on Conservation and Sustainable Use of Wild Fungi’, organized by the Regional Government of Andalucia, Spain, 10–16 December, pp 298–299

    Google Scholar 

  • Yongabi A (2014) Current developments in mushroom biotechnology in sub Saharan Africa. WSMBMP Bull 11:4–13

    Google Scholar 

  • Yongabi K, Agho M, Martinez-Carrera D (2004) Ethnomycological studies on wild mushrooms in Cameroon, Central Africa. Micologia Aplicada Int 16(2):34–36

    Google Scholar 

  • Yongabi A, Laura D, Keto M, Suki KKM, Alex D, Francisca NN (2015) Can we exploit and adapt indigenous knowledge and ethnobotanicals for a healthy living in the face of emerging diseases like Ebola in Africa. Am J Clin Exp Med 3:24–28. https://doi.org/10.11648/jcem.s.2015030101.15

    Article  Google Scholar 

  • Yusof NL, Wee A, Lim LY, Khor E (2003) Flexible chitin films as potential wound-dressing materials: wound model studies. J Biomed Mater: Res A 66(2):224–232

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Yongabi, K.A. (2019). African Medicinal Mushrooms: Source of Biopharmaceuticals for the Treatment of Noncommunicable Diseases – A Review. In: Agrawal, D., Dhanasekaran, M. (eds) Medicinal Mushrooms. Springer, Singapore. https://doi.org/10.1007/978-981-13-6382-5_13

Download citation

Publish with us

Policies and ethics